Dana Farber Cancer Institute SC-12

Boston, Massachusetts 02115

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
ALK-positive Non-small Cell Lung Cancer Clinical Trial
A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials